James R. Tobin's Insider Trades & SAST Disclosures
James R. Tobin's most recent trade in Lyra Therapeutics Inc was a trade of 32,000 Restricted Stock Units done . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James R. Tobin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lyra Therapeutics Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 32,000 | 32,000 | - | - | Restricted Stock Units | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Transmedics Group Inc | James R. Tobin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Sep 2024 | 18,000 | 18,000 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | James R. Tobin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Sep 2024 | 18,000 | 155,146 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 158.96 per share. | 08 Aug 2024 | 12,664 | 180,482 (0%) | 0% | 159.0 | 2,013,069 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 159.96 per share. | 08 Aug 2024 | 7,336 | 173,146 (0%) | 0% | 160.0 | 1,173,467 | Common Stock |
| Lyra Therapeutics Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 30,000 | 30,000 | - | - | Stock Option | |
| Transmedics Group Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,154 | 1,154 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 732 | 1,925 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 125.26 per share. | 03 May 2024 | 6,895 | 193,146 (0%) | 0% | 125.3 | 863,668 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 124.76 per share. | 03 May 2024 | 5,130 | 200,041 (0%) | 0% | 124.8 | 640,019 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 105.70 per share. | 01 May 2024 | 11,236 | 208,975 (0%) | 0% | 105.7 | 1,187,645 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 01 May 2024 | 2,000 | 205,171 (0%) | 0% | 110 | 220,000 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 106.89 per share. | 01 May 2024 | 1,704 | 207,271 (0%) | 0% | 106.9 | 182,141 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 108.47 per share. | 01 May 2024 | 100 | 207,171 (0%) | 0% | 108.5 | 10,847 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 83.63 per share. | 01 Mar 2024 | 5,746 | 223,411 (1%) | 0% | 83.6 | 480,538 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 82.84 per share. | 01 Mar 2024 | 4,234 | 229,157 (1%) | 0% | 82.8 | 350,745 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 84.74 per share. | 01 Mar 2024 | 2,900 | 220,511 (1%) | 0% | 84.7 | 245,746 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 85.48 per share. | 01 Mar 2024 | 300 | 220,211 (1%) | 0% | 85.5 | 25,644 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 81.41 per share. | 01 Mar 2024 | 200 | 233,391 (1%) | 0% | 81.4 | 16,282 | Common Stock |
| Globus Medical Inc - Ordin... | James Tobin R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Lyra Therapeutics Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option | |
| Transmedics Group Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,916 | 1,916 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,193 | 1,193 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 75.13 per share. | 23 Feb 2023 | 10,000 | 243,591 (1%) | 0% | 75.1 | 751,300 | Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 39.98 per share. | 29 Jul 2022 | 48,515 | 253,591 (1%) | 0% | 40.0 | 1,939,630 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 05 Jul 2022 | 48,515 | 302,106 (1%) | 0% | 35 | 1,698,025 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 29.94 per share. | 04 May 2022 | 48,516 | 350,621 (1%) | 0% | 29.9 | 1,452,569 | Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 65.47 per share. | 15 Mar 2022 | 8,850 | 0 (0%) | 0% | 65.5 | 579,418 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 5,308 | 5,208 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.58 per share. | 15 Mar 2022 | 5,308 | 5,308 (0%) | 0% | 43.6 | 231,323 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.27 per share. | 15 Mar 2022 | 3,542 | 8,850 (0%) | 0% | 53.3 | 188,682 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2022 | 3,542 | 21,458 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 70.04 per share. | 08 Mar 2022 | 10,000 | 0 (0%) | 0% | 70.0 | 700,398 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.58 per share. | 08 Mar 2022 | 10,000 | 10,000 (0%) | 0% | 43.6 | 435,800 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 10,000 | 10,516 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 4,484 | 20,516 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 72.00 per share. | 08 Mar 2022 | 4,484 | 0 (0%) | 0% | 72 | 322,848 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.58 per share. | 08 Mar 2022 | 4,484 | 4,484 (0%) | 0% | 43.6 | 195,413 | Class A Common Stock |
| Lyra Therapeutics Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 14,500 | 14,500 | - | - | Stock Option | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Transmedics Group Inc | James R. Tobin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Dec 2021 | 25,500 | 399,137 (1%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 71.96 per share. | 10 May 2021 | 25,000 | 0 (0%) | 0% | 72.0 | 1,799,000 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 25,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.77 per share. | 10 May 2021 | 25,000 | 25,000 (0%) | 0% | 43.8 | 1,094,250 | Class A Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 32.80 per share. | 09 Feb 2021 | 9,968 | 424,837 (2%) | 0% | 32.8 | 326,950 | Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 34.18 per share. | 09 Feb 2021 | 200 | 424,637 (2%) | 0% | 34.2 | 6,836 | Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 56.85 per share. | 02 Sep 2020 | 5,600 | 0 (0%) | 0% | 56.9 | 318,360 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2020 | 5,600 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.27 per share. | 02 Sep 2020 | 5,600 | 5,600 (0%) | 0% | 26.3 | 147,112 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Sale of securities on an exchange or to another person at price $ 54.40 per share. | 25 Aug 2020 | 17,400 | 0 (0%) | 0% | 54.4 | 946,560 | Class A Common Stock |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2020 | 17,400 | 5,600 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc - Ordin... | James R. Tobin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.27 per share. | 25 Aug 2020 | 17,400 | 17,400 (0%) | 0% | 26.3 | 457,098 | Class A Common Stock |
| Transmedics Group Inc | James R. Tobin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 15,934 | 15,934 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges